SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193805-08-001300
Filing Date
2008-05-12
Accepted
2008-05-12 12:50:50
Documents
1
Group Members
INVUS PUBLIC EQUITIES ADVISORS, L.L.C.INVUS PUBLIC EQUITIES, L.P.RAYMOND DEBBANEULYS, L.L.C.

Document Format Files

Seq Description Document Type Size
1 e603798_sc13ga-antigenics.txt SC 13G/A 20551
  Complete submission text file 0001193805-08-001300.txt   22615
Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200
ANTIGENICS INC /DE/ (Subject) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60419 | Film No.: 08821928
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 135 EAST 57, 30 TH FLOOR NEW YORK NY 10022
Business Address 135 EAST 57, 30 TH FLOOR NEW YORK NY 10022 212-317-7520
Invus Public Equities, LP (Filed by) CIK: 0001340097 (see all company filings)

IRS No.: 980420215
Type: SC 13G/A